Delivery Order SPE2DB25D6040-SPE2DB25FTSZV
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $1,897.68 to AmerisourceBergen Drug Corp for the supply of Junel 1.5 mg-30 mcg tablets (21-count) on September 19, 2025, with completion expected by September 22, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value pharmaceutical transaction executed under a non-set-aside procurement. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania....
- The Defense Logistics Agency awarded a delivery order valued at $3,570.36 to AmerisourceBergen Drug Corp on August 19, 2025, for the supply of Junel FE 1.5 mg-30 mcg tablets (28-count packages). This firm fixed price, non-set-aside delivery order is scheduled for completion by August 20, 2025, with performance occurring at the contractor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The Defense Logistics Agency awarded a delivery order valued at $1,011.54 to AmerisourceBergen Drug Corp for the supply of Junel FE 1.5 mg-30 mcg tablets in a 28-count package. This competitively awarded, firm fixed-price contract was issued on July 31, 2025, with an ultimate completion date of August 1, 2025. The contractor will perform work at its corporate office location in Conshohocken, Pennsylvania. This delivery order represents a routine pharmaceutical procurement supporting federal...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on September 10, 2025, for the supply of Junel FE 1.5 mg–30 mcg tablets in quantities of 28, valued at $7,365.86. This is a firm fixed-price delivery order with no set-aside designation, executed through open competition. The work is to be performed at the contractor's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of September 11, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $2,623.20 to AmerisourceBergen Drug Corp for the supply of Junel FE 1 mg-20 mcg tablets (28-count packages). This non-set-aside, competitively awarded contract utilizes firm fixed price pricing and has an ultimate completion date of August 25, 2025. The delivery order was issued on August 22, 2025, with performance occurring at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Junel FE 1.5 mg-30 mcg tablets in quantities of 28 tablets, with a contract ceiling value of $1,201.82. This firm fixed-price delivery order, which is expected to be completed by August 27, 2025, represents a competitively awarded, non-set-aside procurement with performance taking place at the contractor's Conshohocken, Pennsylvania location. AmerisourceBergen Drug Corp, a...
- The Defense Logistics Agency awarded a delivery order valued at $1,065.18 to AmerisourceBergen Drug Corp for the supply of Junel FE 1.5 mg-30 mcg tablets (28-count packages) under a firm fixed-price arrangement. The award, issued on May 21, 2025, with an ultimate completion date of May 22, 2025, represents a non-set-aside competitive procurement. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for...
- The Defense Logistics Agency awarded a $2,046.60 delivery order to AmerisourceBergen Drug Corp for Junel FE 1 mg-20 mcg tablets (28-count packaging) on July 22, 2025, with completion scheduled for July 23, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and will be performed at the contractor's facility in Conshohocken, Pennsylvania. The delivery order represents a continuation of AmerisourceBergen's role as a critical pharmaceutical supplier to the...
- The Defense Logistics Agency awarded a delivery order valued at $3,747.10 to AmerisourceBergen Drug Corp for Junel FE 1 mg-20 mcg tablets (28-count packages) on August 7, 2025, with a completion date of August 8, 2025. This firm fixed-price delivery order was competitively awarded without set-aside designation and represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical. The product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 11, 2025, for the supply of Junel FE 1 mg-20 mcg tablets (28-count) at a firm fixed price ceiling value of $3,808.80. This is a non-set-aside, competitively awarded contract with an ultimate completion date of September 12, 2025. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor and critical vendor for federal medical procurement,...
- SPE2DB25D6040Indefinite Delivery Contract
- SPE2DB25D6040-SPE2DB25FTSZVDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $2,841.20 to AmerisourceBergen Drug Corp for the supply of Junel 1.5 mg-30 mcg tablets (21-count packages) on August 15, 2025, with an ultimate completion date of August 18, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, was selected to fulfill this pharmaceutical supply requirement for federal medical procurement needs. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which carries a potential value of $999,999,999.00 and extends through December 2026. This comprehensive global pharmaceutical support vehicle enables the contractor to supply a broad range of pharmaceutical products and medical supplies to support military healthcare programs worldwide, serving customers including the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems. The contract represents AmerisourceBergen's substantial role in the federal medical supply chain, particularly as DLA Troop Support plans to establish next-generation Pharmaceutical Prime Vendor Global Program contracts across multiple regions.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.8k | 8/15/25 |